Association between brain natriuretic peptide and invasive hemodynamics in left ventricular assist device HeartMate3-supported patients.

IF 1.6 4区 医学 Q4 ENGINEERING, BIOMEDICAL
Elie Kozaily, Azalfa Lateef, Vishal N Rao, Gregory R Jackson, Anthony P Carnicelli, Chakradhari Inampudi, Lucas Witer, Mabelissa Geagea, Arman Kilic, Walker Blanding, Ryan J Tedford, Brian A Houston
{"title":"Association between brain natriuretic peptide and invasive hemodynamics in left ventricular assist device HeartMate3-supported patients.","authors":"Elie Kozaily, Azalfa Lateef, Vishal N Rao, Gregory R Jackson, Anthony P Carnicelli, Chakradhari Inampudi, Lucas Witer, Mabelissa Geagea, Arman Kilic, Walker Blanding, Ryan J Tedford, Brian A Houston","doi":"10.1177/03913988261473044","DOIUrl":null,"url":null,"abstract":"<p><p>We report a serum BNP cut-off of 800 pg/mL above which all patients with LVAD HeartMate-3 had elevated biventricular filling pressures, suggesting it may be used to prompt invasive ramp study during routine post-LVAD clinic visit. We found stepwise increase in BNP levels across hemodynamic groups, with the lowest levels in patients with normal filling pressures, intermediate in those with elevated right or left-sided filling pressure and highest in those with elevated biventricular filling pressures. Furthermore, most patients with BNP above median value (335 pg/mL) required speed changes for either elevated right sided or left sided filling pressures. Conversely, patients with BNP below 335 pg/mL rarely required speed change. In conclusion, elevated serum BNP in patients with durable LVAD HeartMate-3 may have clinical value in prompting invasive hemodynamic assessment.</p>","PeriodicalId":13932,"journal":{"name":"International Journal of Artificial Organs","volume":" ","pages":"834-836"},"PeriodicalIF":1.6000,"publicationDate":"2026-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Artificial Organs","FirstCategoryId":"5","ListUrlMain":"https://doi.org/10.1177/03913988261473044","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/8/12 0:00:00","PubModel":"Epub","JCR":"Q4","JCRName":"ENGINEERING, BIOMEDICAL","Score":null,"Total":0}
引用次数: 0

Abstract

We report a serum BNP cut-off of 800 pg/mL above which all patients with LVAD HeartMate-3 had elevated biventricular filling pressures, suggesting it may be used to prompt invasive ramp study during routine post-LVAD clinic visit. We found stepwise increase in BNP levels across hemodynamic groups, with the lowest levels in patients with normal filling pressures, intermediate in those with elevated right or left-sided filling pressure and highest in those with elevated biventricular filling pressures. Furthermore, most patients with BNP above median value (335 pg/mL) required speed changes for either elevated right sided or left sided filling pressures. Conversely, patients with BNP below 335 pg/mL rarely required speed change. In conclusion, elevated serum BNP in patients with durable LVAD HeartMate-3 may have clinical value in prompting invasive hemodynamic assessment.

左心室辅助装置heartmate3支持下患者脑利钠肽与侵入性血流动力学的关系。
我们报告了血清BNP临界值为800 pg/mL以上,所有LVAD患者HeartMate-3均有双心室充盈压力升高,这表明该临界值可用于LVAD后常规门诊就诊时的有创斜坡研究。我们发现在血流动力学组中BNP水平逐步升高,正常充盈压力的患者水平最低,右侧或左侧充盈压力升高的患者水平中等,双室充盈压力升高的患者水平最高。此外,大多数BNP高于中位值(335 pg/mL)的患者需要改变右侧或左侧填充压力升高的速度。相反,BNP低于335 pg/mL的患者很少需要改变速度。综上所述,持久LVAD患者的血清BNP升高可能对促进有创血流动力学评估具有临床价值。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
International Journal of Artificial Organs
International Journal of Artificial Organs 医学-工程:生物医学
CiteScore
3.40
自引率
5.90%
发文量
92
审稿时长
3 months
期刊介绍: The International Journal of Artificial Organs (IJAO) publishes peer-reviewed research and clinical, experimental and theoretical, contributions to the field of artificial, bioartificial and tissue-engineered organs. The mission of the IJAO is to foster the development and optimization of artificial, bioartificial and tissue-engineered organs, for implantation or use in procedures, to treat functional deficits of all human tissues and organs.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书